|
|
|
|
|
 | | Ramanan Laxminarayan | | Senior Fellow | |
|
|
Profile |
Ramanan Laxminarayan is a senior fellow at Resources for the Future, where he directs the Center for Disease Dynamics, Economics, and Policy, and a visiting scholar and lecturer at Princeton University. His research deals with the integration of epidemiological models of infectious diseases and drug resistance into the economic analysis of public health problems. He has worked to improve understanding drug resistance as a problem of managing a shared global resource. Laxminarayan has worked with the World Health Organization (WHO) and the World Bank on evaluating malaria treatment policy, vaccination strategies, the economic burden of tuberculosis, and control of non-communicable diseases. He has served on a number of advisory committees at WHO, Centers for Disease Control and, Prevention, and the Institute of Medicine. In 2003-04, he served on the National Academy of Science/Institute of Medicine Committee on the Economics of Antimalarial Drugs and subsequently helped create the Affordable Medicines Facility for malaria, a novel financing mechanism for antimalarials. His work has been covered in major media outlets including Associated Press, BBC, CNN, the Economist, LA Times, NBC, NPR, Reuters, Science, Wall Street Journal, and National Journal.
Laxminarayan received his undergraduate degree in engineering from the Birla Institute of Technology and Science in Pilani, India, and his master’s degree in public health (Epidemiology) and doctorate in economics from the University of Washington in Seattle.
|
|
|
|
| Featured Publications | | Clinical and Economic Outcomes Attributable to Health Care-Associated Sepsis and Pneumonia | | Eber M.R., Laxminarayan R., Perencevich E.N., Malani A. | | Archives of Internal Medicine | 2010 | Vol. 170, No. 4 | pp. 347-353 | | | | Managing Partially Protected Resources under Uncertainty | | Carolyn Fischer, Ramanan Laxminarayan | | Journal of Environmental Economics and Management | Vol. 59, No. 2 | pp. 129-141 | | | | Will global subsidy of new antimalarials delay the emergence of resistance and save lives? | | Laxminarayan R., Mead Over, David Smith | | Health Affairs | 2006 | Vol. 25, No. 2 | pp. 325-6 | | | | Advancing Global Health: Key Messages from the Disease Control Priorities Project | | Laxminarayan R., D.T. Jamison, A. Mills, J. Breman, A. Measham, G. Alleyne, M. Claeson, P. Jha, P. Musgrove, J. Chow, S. Shahid-Salles. | | The Lancet | 2006 | Vol. 367, No. 9517 | pp. 1193-1208 | | | | Strategic Interactions in Multi-institution Epidemics of Antibiotic Resistance | | Smith D.L., S.A.Levin, R. Laxminarayan | | Proceedings of the National Academy of Sciences | 2005 | Vol. 102, No. 8 | pp. 3153-3158 | | | | Sequential Development and Exploitation of an Exhaustible Resource: Do Monopoly Rights Promote Conservation? | | Carolyn Fischer and Ramanan Laxminarayan | | Journal of Environmental Economics and Management | 2004 | Vol. 49., No. 3 | pp. 500-515 | | | | Economics of Antibiotic Resistance: A Theory of Optimal Use | | Ramanan Laxminarayan and Gardner M. Brown | | Journal of Environmental Economics and Management | 2001 | Vol. 42, No. 2 | pp. 183-206 | Related Discussion Paper 00-36 | | | | View All Related Publications |
|
|
|
|
|
|
|
|